Robert Kramer, Emergent BioSolutions CEO
November 17, 2022 10:57 AM ESTUpdated 11:19 AM
Financing
Manufacturing

Emer­gent scores a DoD award to eval­u­ate its chikun­gun­ya vac­cine in the field

Tyler Patchen

News Reporter

Emer­gent BioSo­lu­tions is look­ing to make progress with its chikun­gun­ya vac­cine and has re­ceived a $10 mil­lion US gov­ern­ment grant to help it along. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

2024's bio­phar­ma win­ners and losers; Ca­griSe­ma falls short; Mer­ck swings Chi­na GLP-1 deal; and more

A service from the Financial Times